Reshape Lifesciences Inc (NAS:RSLS)
$ 5.915 -0.105 (-1.74%) Market Cap: 3.00 Mil Enterprise Value: 2.21 Mil PE Ratio: 0 PB Ratio: 0.99 GF Score: 64/100

Q2 2019 Obalon Therapeutics Inc Earnings Call Transcript

Jul 24, 2019 / 12:30PM GMT
Operator

Good day, ladies and gentlemen, and welcome to the Obalon Therapeutics Second Quarter 2019 Financial Results Conference Call. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to turn the conference over to Bill Plovanic, President and Chief Financial Officer for Obalon. You may begin.

William John Plovanic
Obalon Therapeutics, Inc. - President, CFO, Secretary & Director

Thank you. Good morning, and welcome to Obalon Therapeutics Second Quarter 2019 Financial Results Conference Call. With me on today's call is Bob MacDonald, Chief Retail Officer of Obalon.

This morning, the company issued a press release detailing our financial results for the 3 and 6 months ended June 30, 2019. This release can be accessed through the Investor Relations section of the Obalon website at obalon.com. You can also access the webcast of this call from there.

Before we get started, I'd like to remind everyone that any statements made on today's conference call that express a belief, expectation, projection, forecast,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot